1832 Asset Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,700
| Closed | -$7.11M | – | 723 |
|
|
2024
Q3 | $7.11M | Buy |
+23,700
| New | +$7.11M | 0.01% | 366 |
|
|
2023
Q3 | – | Sell |
-5
| Closed | -$1.91K | – | 921 |
|
|
2023
Q2 | $1.91K | Buy |
+5
| New | +$1.91K | ﹤0.01% | 815 |
|
|
2022
Q2 | – | Sell |
-753
| Closed | -$305K | – | 939 |
|
|
2022
Q1 | $305K | Buy |
+753
| New | +$305K | ﹤0.01% | 660 |
|
|
2021
Q4 | – | Sell |
-523
| Closed | -$228K | – | 875 |
|
|
2021
Q3 | $228K | Buy |
+523
| New | +$228K | ﹤0.01% | 668 |
|
|
2020
Q4 | – | Sell |
-482,200
| Closed | -$133M | – | 753 |
|
|
2020
Q3 | $133M | Buy |
482,200
+65,400
| +16% | +$18M | 0.35% | 85 |
|
|
2020
Q2 | $92.5M | Buy |
+416,800
| New | +$92.5M | 0.28% | 94 |
|
|
2019
Q1 | – | Sell |
-878,420
| Closed | -$86.1M | – | 719 |
|
|
2018
Q4 | $86.1M | Buy |
878,420
+2,400
| +0.3% | +$235K | 0.34% | 74 |
|
|
2018
Q3 | $108M | Buy |
876,020
+217,460
| +33% | +$26.9M | 0.35% | 72 |
|
|
2018
Q2 | $65.4M | Sell |
658,560
-143,470
| -18% | -$14.2M | 0.22% | 103 |
|
|
2018
Q1 | $71.2M | Buy |
802,030
+88,670
| +12% | +$7.87M | 0.26% | 95 |
|
|
2017
Q4 | $70.1M | Buy |
713,360
+65,390
| +10% | +$6.43M | 0.23% | 96 |
|
|
2017
Q3 | $60.5M | Buy |
647,970
+372,070
| +135% | +$34.7M | 0.21% | 96 |
|
|
2017
Q2 | $26.1M | Buy |
275,900
+166,200
| +152% | +$15.7M | 0.12% | 163 |
|
|
2017
Q1 | $8.97M | Buy |
+109,700
| New | +$8.97M | 0.03% | 267 |
|